| |
| |
|
| Insider
Information: |
Kolchinsky Peter |
| Relationship: |
Director, 10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
21 |
|
| Direct
Shares |
6,648,738 |
|
|
Indirect Shares
|
89,615,900 |
|
|
| Direct
Value |
$30,628,641 |
|
|
|
Indirect Value
|
$935,155,980 |
|
|
| Total
Shares |
96,264,638 |
|
|
| Total
Value |
$965,784,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 14.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WVE |
Wave Life Sciences Ltd. |
Director |
– • • |
2017-11-14 |
4 |
B |
$24.00 |
$561,550 |
I/I |
23,398 |
7,512,049 |
2.25 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
– – • |
2015-10-19 |
4 |
B |
$14.88 |
$356,049 |
I/I |
23,934 |
2,303,877 |
1.5 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-09-20 |
4 |
S |
$7.40 |
$196,481 |
D/D |
(26,539) |
5,039,346 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-08-01 |
4 |
S |
$12.82 |
$356,100 |
D/D |
(27,770) |
1,829,426 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-05-12 |
4 |
S |
$13.01 |
$386,330 |
D/D |
(29,659) |
4,745,013 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-27 |
4 |
S |
$19.26 |
$623,499 |
D/D |
(32,196) |
3,725,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-09-23 |
4 |
S |
$7.42 |
$248,134 |
D/D |
(33,448) |
5,071,550 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-04-07 |
4 |
B |
$15.42 |
$519,310 |
D/D |
33,667 |
4,475,024 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-07 |
4 |
S |
$18.52 |
$642,432 |
D/D |
(34,688) |
3,683,002 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-20 |
4 |
S |
$18.39 |
$649,869 |
D/D |
(35,319) |
3,683,002 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-05-07 |
4 |
B |
$12.09 |
$431,870 |
D/D |
35,736 |
4,857,972 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-07-17 |
4 |
B |
$12.26 |
$456,211 |
D/D |
37,215 |
2,199,753 |
2.44 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-07-25 |
4 |
B |
$7.19 |
$268,003 |
D/D |
37,250 |
5,310,452 |
2.45 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-07-17 |
4 |
B |
$7.09 |
$272,387 |
D/D |
38,400 |
5,365,873 |
2.45 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-07-19 |
4 |
S |
$7.21 |
$276,960 |
D/D |
(38,400) |
5,327,473 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-08-20 |
4 |
B |
$6.75 |
$259,844 |
D/D |
38,500 |
5,237,106 |
2.45 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-08-28 |
4 |
B |
$6.39 |
$245,823 |
D/D |
38,500 |
4,906,117 |
2.45 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-09-11 |
4 |
B |
$7.18 |
$279,069 |
D/D |
38,800 |
4,848,217 |
2.45 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-09-11 |
4 |
S |
$7.30 |
$283,240 |
D/D |
(38,800) |
4,828,817 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-04-17 |
4 |
B |
$14.02 |
$581,959 |
D/D |
41,500 |
4,762,078 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-05 |
4 |
B |
$18.17 |
$765,828 |
D/D |
42,000 |
3,725,002 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-11 |
4 |
B |
$19.65 |
$825,275 |
D/D |
42,000 |
3,725,002 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-12 |
4 |
B |
$18.04 |
$757,621 |
D/D |
42,000 |
3,767,002 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-28 |
4 |
B |
$18.10 |
$760,145 |
D/D |
42,000 |
3,767,000 |
2.44 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
– – • |
2015-10-14 |
4 |
B |
$14.06 |
$601,792 |
I/I |
42,813 |
2,279,943 |
1.5 |
- |
|
207 Records found
|
|
Page 3 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
